Pattern names localize injury; function tests tell you whether the liver is keeping up.
Reference image for orientation, not a diagnostic studyAminotransferases reflect injury, while bilirubin, INR, albumin, and platelets better reveal excretory, synthetic, and portal consequences.https://www.calmview.co.uk/BartsHealth/CalmView/Record.aspx?src=CalmView.Catalog&id=SBHB%2fMU%2f14%2f21%2f23&pos=1 / Wikimedia Commons (CC BY 4.0). SourceCC BY 4.0
Classify hepatocellular, cholestatic, and mixed injury with the R factor.
Use AST, ALT, ALP, GGT, and bilirubin without overcalling nonspecific patterns.
Separate injury markers from synthetic and portal-hypertension markers and triage severe aminotransferase elevation.
Rounds dashboard
See the whole liver patient
The dashboard keeps injury pattern, function, complications, and next action visible together.
Quick check
A 44-year-old has ALT 360 U/L with ULN 40 and ALP 180 U/L with ULN 120 after starting a new supplement. Bilirubin is 2.1 mg/dL.
What is the most appropriate next step?
Reason it through
What are the normalized enzyme ratios?ALT is 9 times ULN and ALP is 1.5 times ULN.
How is R calculated?Normalized ALT divided by normalized ALP.
What does R equal 6 mean?R at least 5 is hepatocellular.
Normalize before dividing; raw enzyme values cannot define the R factor.
Calculate the R factor
The R factor standardizes an enzyme pattern at presentation.
R equals (ALT divided by ALT ULN) divided by (ALP divided by ALP ULN). Use simultaneous values and the reporting laboratory's own upper limits.
R at least 5 is hepatocellular, R 2 or less is cholestatic, and R above 2 but below 5 is mixed.
Place the cut points and example values on the classification axis.
R factor classifies the biochemical pattern; it does not name the disease.
Injury pattern is not liver function
Enzymes leak or accumulate with injury; albumin and clotting factors reflect hepatic production.
AST and ALT indicate hepatocellular injury but do not measure functional reserve. ALP rises with cholestasis but also comes from bone and placenta.
Bilirubin reflects uptake, conjugation, and excretion. Albumin and INR help assess synthesis, though each has important nonhepatic confounders.
Compare the three biochemical patterns.
AST and ALT predominate; consider viral, toxic, ischemic, autoimmune, metabolic, and vascular causes.
ALP predominates; assess medication causes and image the biliary tree for obstruction.
Both aminotransferases and ALP are substantially elevated; drug-induced injury is a key consideration.
Rising INR not explained by anticoagulation or vitamin K deficiency and low albumin in chronic disease indicate reduced production, not an enzyme pattern.
A patient can have severe functional failure with only modest enzyme elevation.
Read the panel in a disciplined order
A reproducible approach prevents ratio folklore from replacing diagnosis.
First confirm the abnormality and urgency, then define the pattern with normalized values.
Next localize nonhepatic sources, review exposures and physiology, and order targeted tests and imaging.
Put the interpretation workflow in order.
Choose the first step.
Ratios are clues, not verdicts
AST and ALT must be interpreted with magnitude, timing, and extrahepatic sources.
AST is present in liver, skeletal and cardiac muscle, and red cells; ALT is more liver-enriched but is not liver-exclusive.
An AST:ALT ratio above 2 supports alcohol-associated hepatitis in the right clinical setting, often with values below 400 U/L, but the ratio is neither necessary nor sufficient.
Identify the accurate interpretation.
Before calling AST hepatic, ask what happened to the muscle.
Localize each signal
The same panel samples hepatocytes, bile flow, synthetic machinery, and portal consequences.
A hepatic ALP rise is commonly accompanied by GGT elevation; an isolated ALP rise with normal GGT points toward bone or another nonhepatic source.
Platelets do not measure synthesis. A falling count can instead reflect portal hypertension with splenic sequestration.
Map each laboratory marker to its dominant compartment.
Start at the first landmark.
Severe aminotransferases narrow the clock
Very high values demand rapid evaluation for time-sensitive causes.
AST or ALT around or above 1,000 U/L strongly raises ischemic hepatitis, acetaminophen or other toxin injury, and acute viral hepatitis; autoimmune hepatitis and acute vascular obstruction also remain possible.
Acute choledocholithiasis can occasionally produce a dramatic transient hepatocellular spike before the cholestatic pattern becomes dominant.
Reveal the next action behind each severe pattern.
Restore perfusion and oxygenation while excluding additional causes.Obtain a level and start N-acetylcysteine promptly when toxicity is possible.Give antibiotics when cholangitis is suspected and arrange urgent biliary decompression.Treat as acute liver failure and contact a transplant center urgently.Check CK and manage rhabdomyolysis.
Stage 1 of 3: Overview
Overview
Liver Enzymes and Synthetic Function
A reproducible approach prevents ratio folklore from replacing diagnosis.
Step by step
Read the panel in a disciplined order
1Check instability and failureAssess mental status, glucose, INR, bilirubin trajectory, lactate, hemodynamics, and signs of acute liver failure.
2Normalize ALT and ALPDivide each result by its own laboratory ULN.
3Calculate the R factorDivide normalized ALT by normalized ALP: at least 5 hepatocellular, 2 or less cholestatic, and between 2 and 5 mixed.
4Confirm tissue sourceUse history, CK, and hemolysis studies for AST; use GGT or ALP isoenzymes when bone versus hepatic ALP is uncertain.
5Search by patternReview medications and supplements, alcohol, viral risk, perfusion, autoimmune clues, metabolic disease, and biliary symptoms.
6Treat the cause and trendStop hepatotoxins, restore perfusion, relieve obstruction, use antidotes when indicated, and follow function as well as enzymes.
Clinical takeaway
Why it mattersNext localize nonhepatic sources, review exposures and physiology, and order targeted tests and imaging.
RememberNormalize before dividing; raw enzyme values cannot define the R factor.
Rounds question
Name today’s management pivot
Choose the clue that changes what the team does on this round.
What is the most appropriate next step?
Key finding. A 44-year-old has ALT 360 U/L with ULN 40 and ALP 180 U/L with ULN 120 after starting a new supplement. Bilirubin is 2.1 mg/dL.
Answer. Hepatocellular injury, R factor 6
Why. R equals (360/40) divided by (180/120), or 9 divided by 1.5, which is 6.
Board rule. Normalize before dividing; raw enzyme values cannot define the R factor.
Run the liver cases
Five laboratory panels test classification, source localization, urgent differential diagnosis, function, and cause-directed treatment.
Cross out premature plans and highlight the finding that changes management. Each case separates injury, function, and complication.
A 39-year-old has ALT 240 U/L (ULN 40) and ALP 360 U/L (ULN 120) after starting amoxicillin-clavulanate. Bilirubin is 3.0 mg/dL.
What is the R factor and pattern?
Reason it through
How high is ALT relative to ULN?Six times ULN.
How high is ALP relative to ULN?Three times ULN.
What is 6 divided by 3?R is 2.0, classified as cholestatic.
Normalize both enzymes before calculating the pattern.
How high is ALT relative to ULN?How high is ALP relative to ULN?
How high is ALT relative to ULN?Six times ULN.
How high is ALP relative to ULN?Three times ULN.
What is 6 divided by 3?R is 2.0, classified as cholestatic.
A 50-year-old with severe muscle pain after a crush injury has AST 620 U/L, ALT 140 U/L, CK 24,000 U/L, normal bilirubin, and normal ALP.
Which explanation best fits the aminotransferase pattern?
Reason it through
Is AST liver-specific?No. Skeletal muscle contains abundant AST.
Which test localizes the source here?The markedly elevated CK.
Can the AST:ALT ratio diagnose alcohol injury here?No. Muscle injury invalidates that shortcut.
A ratio cannot outrank tissue context.
Is AST liver-specific?Which test localizes the source here?
Is AST liver-specific?No. Skeletal muscle contains abundant AST.
Which test localizes the source here?The markedly elevated CK.
Can the AST:ALT ratio diagnose alcohol injury here?No. Muscle injury invalidates that shortcut.
A 23-year-old presents 24 hours after an uncertain acetaminophen ingestion with nausea. ALT is 1,850 U/L and INR is 1.8; the acetaminophen level is low but detectable.
What is the best immediate treatment?
Reason it through
Why can the drug level look unimpressive?The patient presents late, after the peak concentration.
Which values show injury and impaired function?ALT shows injury; INR suggests impaired clotting-factor synthesis.
Should treatment wait for certainty?No. Start N-acetylcysteine promptly when toxicity is plausible.
In suspected acetaminophen injury, the clock matters more than a late low level.
Why can the drug level look unimpressive?Which values show injury and impaired function?
Why can the drug level look unimpressive?The patient presents late, after the peak concentration.
Which values show injury and impaired function?ALT shows injury; INR suggests impaired clotting-factor synthesis.
Should treatment wait for certainty?No. Start N-acetylcysteine promptly when toxicity is plausible.
A 72-year-old has pruritus, dark urine, ALP 610 U/L, GGT 490 U/L, ALT 95 U/L, and direct hyperbilirubinemia. Ultrasound shows a dilated common bile duct.
What does the panel most strongly indicate?
Reason it through
Which enzyme dominates?ALP dominates over ALT.
What does GGT add?It supports hepatobiliary origin of the ALP.
What localizes an extrahepatic block?Common bile duct dilation on ultrasound.
Cholestatic chemistry plus duct dilation shifts the task from labeling to relieving obstruction.
Which enzyme dominates?What does GGT add?
Which enzyme dominates?ALP dominates over ALT.
What does GGT add?It supports hepatobiliary origin of the ALP.
What localizes an extrahepatic block?Common bile duct dilation on ultrasound.
A 60-year-old with a nodular liver has AST 48 U/L, ALT 42 U/L, albumin 2.7 g/dL, INR 1.7 without anticoagulation, bilirubin 4.3 mg/dL, and platelets 74,000/mm3.
Which interpretation is most accurate?
Reason it through
Which tests describe active injury?AST and ALT.
Which values raise concern for poor synthesis?Low albumin and elevated INR.
What does thrombocytopenia suggest here?Portal hypertension with splenic sequestration is likely.
Quiet enzymes do not mean a healthy liver.
Which tests describe active injury?Which values raise concern for poor synthesis?
Which tests describe active injury?AST and ALT.
Which values raise concern for poor synthesis?Low albumin and elevated INR.
What does thrombocytopenia suggest here?Portal hypertension with splenic sequestration is likely.
Rapid review
Three questions to check
What is the most appropriate next step?
Hepatocellular injury, R factor 6. R equals (360/40) divided by (180/120), or 9 divided by 1.5, which is 6.
Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.
